Combining radiation with immune checkpoint inhibitors therapy for HCC: From the alteration of the immune microenvironment by radiotherapy

Hepatocellular carcinoma (HCC), one of the deadliest cancers all over the world, had a limited prognosis in the past. Recently, the remarkable efficacy of immune checkpoint inhibitors (ICIs) therapy has been shown in various solid tumors. What's more, the occurrence of HCC is associated with im...

Full description

Bibliographic Details

Published in:	Radiation Medicine and Protection
Main Authors:	Kaixiao Zhou, Yabo Jiang, Shuang Feng, Tingya Wang, Lili Wang, Jianping Cao, Yang Jiao
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Subjects:	Radiotherapy Immune checkpoint inhibitors (ICIs) therapy Hepatocellular carcinoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666555722000454